Inovio Pharmaceuticals, Inc. (INO)
1.335
+0.06
(+5.12%)
USD |
NASDAQ |
Sep 01, 16:00
1.31
-0.02
(-1.87%)
After-Hours: 18:49
Inovio Pharmaceuticals Net Income (TTM) : -67.43M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -67.43M |
| March 31, 2026 | -84.93M |
| December 31, 2025 | -84.95M |
| September 30, 2025 | -108.09M |
| June 30, 2025 | -87.76M |
| March 31, 2025 | -96.48M |
| December 31, 2024 | -107.25M |
| September 30, 2024 | -112.88M |
| June 30, 2024 | -121.64M |
| March 31, 2024 | -124.94M |
| December 31, 2023 | -135.12M |
| September 30, 2023 | -164.58M |
| June 30, 2023 | -168.43M |
| March 31, 2023 | -241.39M |
| December 31, 2022 | -279.82M |
| September 30, 2022 | -332.30M |
| June 30, 2022 | -354.69M |
| March 31, 2022 | -328.33M |
| December 31, 2021 | -303.66M |
| September 30, 2021 | -221.05M |
| June 30, 2021 | -141.71M |
| March 31, 2021 | -188.74M |
| December 31, 2020 | -167.47M |
| September 30, 2020 | -181.28M |
| June 30, 2020 | -223.99M |
| Date | Value |
|---|---|
| March 31, 2020 | -124.40M |
| December 31, 2019 | -120.55M |
| September 30, 2019 | -115.37M |
| June 30, 2019 | -116.85M |
| March 31, 2019 | -93.91M |
| December 31, 2018 | -96.97M |
| September 30, 2018 | -85.51M |
| June 30, 2018 | -94.63M |
| March 31, 2018 | -97.47M |
| December 31, 2017 | -88.21M |
| September 30, 2017 | -92.93M |
| June 30, 2017 | -79.56M |
| March 31, 2017 | -88.78M |
| December 31, 2016 | -73.74M |
| September 30, 2016 | -65.46M |
| June 30, 2016 | -39.11M |
| March 31, 2016 | -26.56M |
| December 31, 2015 | -29.10M |
| September 30, 2015 | -18.56M |
| June 30, 2015 | -31.34M |
| March 31, 2015 | -35.89M |
| December 31, 2014 | -36.14M |
| September 30, 2014 | -44.20M |
| June 30, 2014 | -67.91M |
| March 31, 2014 | -68.06M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Fortress Biotech, Inc. | 141.19M |
| Tonix Pharmaceuticals Holding Corp. | -159.67M |
| Kura Oncology, Inc. | -296.78M |
| Spero Therapeutics, Inc. | 7.383M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |